Marilena Caresana

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with <i>de novo</i> primary myelodysplastic syndromes

Paolo Bernasconi, Catherine Klersy, Marina Boni et al. · British Journal of Haematology · 2007 · 95 citations

Cytogenetics, Genetics, Genetic Epidemiology +21

Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution

Paolo Bernasconi, Catherine Klersy, Marina Boni et al. · Leukemia · 2005 · 86 citations

Karyotype Imaging, Hematological Malignancy, Bone Marrow Failure +10

Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients

Paolo Bernasconi, Paola Maria Cavigliano, Marina Boni et al. · Leukemia · 2003 · 66 citations

Hematological Malignancy, Bone Marrow Failure, Cytogenetics +12

Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea

Paolo Bernasconi, Marina Boni, PM Cavigliano et al. · Leukemia · 2002 · 38 citations

Hematological Malignancy, Thrombosis, Essential Thrombocythemia +7

Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution

Paolo Bernasconi, Catherine Klersy, Marina Boni et al. · Annals of Hematology · 2010 · 23 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Mixed-phenotype Acute Leukemia +10